Julie Brahmer, MD

Baltimore, Maryland 21287

0 studies enrolling now · 1 studies all time

What they study most

Epigenetic Therapy, Non-Small Cell Lung Cancer

Studies at this site

• Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC. — Completed